Initial preliminary results from the Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study, based on close to 6,000 dried blood spot samples collected between February 8 and May 17, 2021, show a high degree of variability in the level of antibodies produced by a single dose of a COVID-19 vaccine. These findings highlight the importance of Read more about Early results from CanPath’s national study confirm antibody levels are stronger after receiving two doses of COVID-19 vaccine[…]

Atlantic PATH is thrilled to be involved in the newly funded project led by Dr. Juliet Daniel at McMaster University. The New Frontiers in Research Fund 2020 Exploration grants target high-risk, high-reward and interdisciplinary research. This work will focus on disparities in cancer incidence and outcomes in a Black Nova Scotian community (Shelburne, Nova Scotia). Read more about New Frontiers in Research Fund 2020 Exploration Grant[…]